Product Information
LACOSAMIDE 150 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2127 per EA under NDC 65862074960. Its NADAC has been published 128 times since Mar 13, 2024.
FDA first approved this application on Jan 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862074960
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LACOSAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204994FDA Approved
1/5/2023
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for LACOSAMIDE 150 MG TABLET has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 39.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2127 per EA |
|---|---|
| All-time high | $0.3650 (Apr 10, 2024) |
| All-time low | $0.2033 (Jul 22, 2026) |
| 52-week high | $0.2502 |
| 52-week low | $0.2033 |
| Median price | $0.2502 |
| Average price | $0.2621 |
| Largest weekly change | +42.0% (Aug 21, 2024) |
| Weeks tracked | 128 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LACOSAMIDE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LACOSAMIDE 150 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.2127 per EA (NDC 65862074960), effective Aug 19, 2026.
How has the price of LACOSAMIDE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for LACOSAMIDE 150 MG TABLET has declined 39.1%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for LACOSAMIDE 150 MG TABLET?
Since Mar 13, 2024, the NADAC for LACOSAMIDE 150 MG TABLET has ranged from a low of $0.2033 (Jul 22, 2026) to a high of $0.3650 (Apr 10, 2024), with a median of $0.2502 per EA.
Are there cheaper alternatives to LACOSAMIDE 150 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LACOSAMIDE 150 MG TABLET, is $0.2069 per EA — about 3% below LACOSAMIDE 150 MG TABLET.
Who manufactures LACOSAMIDE 150 MG TABLET?
LACOSAMIDE 150 MG TABLET (NDC 65862074960) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.